Developing coatings to protect transplanted insulin-producing cells
Engineering Immunomodulatory Nanoscale Coatings for Protecting Islet Transplants
This study is exploring new ways to help people with Type 1 diabetes have more successful islet transplants by using special coatings that protect the transplanted cells from being rejected by the body’s immune system.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Florida NIH-funded |
| Lab location | 1 site (Gainesville, United States) |
| Project ID | NIH-10890131 on NIH RePORTER |
What this research studies
This research focuses on improving the success of islet transplantation for patients with Type 1 diabetes by creating innovative nanoscale coatings that protect the transplanted cells from immune rejection. The approach involves using advanced polymeric materials that can modulate the immune response, helping to maintain the function of the transplanted islets. By utilizing bio-orthogonal chemistry, the coatings aim to mask the donor cell surface proteins and create a supportive environment that encourages tolerance from the recipient's immune system. This could lead to better long-term outcomes for patients receiving islet transplants.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with Type 1 diabetes who are considering or are eligible for islet transplantation.
Not a fit: Patients who do not have Type 1 diabetes or those who are not candidates for islet transplantation may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly enhance the longevity and functionality of islet transplants, providing a more effective treatment option for Type 1 diabetes.
How similar studies have performed: Previous research has shown promise with similar immunomodulatory approaches in animal models, but this specific application in human islet transplantation is still being explored.
Where this research is happening
Gainesville, United States
- University of Florida — Gainesville, United States (Active)
Researchers
- Principal investigator: Stabler, Cherie L — University of Florida
- Study coordinator: Stabler, Cherie L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.